This guest post comes courtesy of Jason Bloomberg, managing partner atZapThink. Take the BriefingsDirect middleware/ESB survey now. On the other hand, there are plenty of enterprise architects who do ...
Simply sign up to the Artificial intelligence myFT Digest -- delivered directly to your inbox. Alphabet-owned Isomorphic Labs is ramping up its operations by poaching pharmaceutical talent and opening ...
The field of drug discovery has been supercharged by the capabilities of AI, which several companies have applied in various ways to turn an enormous practical problem into a tractable information ...
Isomorphic Labs Inc., a healthcare startup that spun out of Alphabet Inc. in 2021, today announced that it has closed a $600 million funding round. OpenAI backer Thrive Capital led the investment. It ...
Last year, Alphabet’s DeepMind announced its AlphaFold 2 AI showed it could predict how certain proteins would fold in a way that was competitive with experimental data. The news was met with ...
AI research wunderkind, DeepMind, has long been all fun and games. The London-based organization, owned by Google parent company Alphabet, has used deep learning to train algorithms that can take down ...
Google DeepMind's spinoff Isomorphic Labs is set to begin human trials of a drug desinged completely by Artificial Intelligence. Isomorphic Labs, a drug discovery company spun out of Google DeepMind, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback